ODVNX
Price
$39.65
Change
+$0.23 (+0.58%)
Updated
Sep 11 closing price
Net Assets
8.91B
RNWHX
Price
$107.05
Change
-$0.71 (-0.66%)
Updated
Sep 11 closing price
Net Assets
90.01B
Interact to see
Advertisement

ODVNX vs RNWHX

ODVNX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
ODVNX vs. RNWHX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ODVNX is a StrongBuy and RNWHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 90B vs. ODVNX (8.91B). RNWHX pays higher dividends than ODVNX: RNWHX (1.15) vs ODVNX (0.16). ODVNX was incepted earlier than RNWHX: ODVNX (26 years) vs RNWHX (11 years). ODVNX (1.55) is less costly to investors than RNWHX (0.72). ODVNX is a more actively managed with annual turnover of: 79.00 vs. RNWHX (46.00). RNWHX has a lower initial minimum investment than ODVNX: RNWHX (250) vs ODVNX (1000). RNWHX annual gain was more profitable for investors over the last year : 17.19 vs. ODVNX (-10.23). RNWHX return over 5 years is better than : 17.68 vs. ODVNX (-23.77).
ODVNXRNWHXODVNX / RNWHX
Total Expense Ratio1.550.72215%
Annual Report Gross Expense Ratio1.550.72215%
Fund Existence26 years11 years-
Gain YTD20.95716.447127%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets8.91B90B10%
Annual Yield % from dividends0.161.1514%
Returns for 1 year-10.2317.19-59%
Returns for 3 years9.0053.8417%
Returns for 5 years-23.7717.68-134%
Returns for 10 years23.59111.4421%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLPEX46.310.28
+0.61%
Fidelity Advisor Low-Priced Stock C
FACDX64.25N/A
N/A
Fidelity Advisor Health Care A
EXHAX26.61N/A
N/A
Manning & Napier Pro-Blend Max Term S
LMCFX35.98N/A
N/A
Lord Abbett Mid Cap Stock F
MSAWX22.51N/A
N/A
Morgan Stanley Inst Asia Opp C